Greater Neighborhood Disadvantage Tied to Inflammatory, Alzheimer Disease Biomarkers
Cross-sectional association seen for greater neighborhood disadvantage with CSF chitinase-3-like protein 1 and tau
Health Care Expenditure Expected to Top GDP Growth 2024 to 2033
National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3 percent by 2033
Chronic Exposure to Systemic Inflammation May Increase Risk for Affective Disorders
Prevalence higher for current depressive symptoms and current anxiety symptoms
ADHD Medications Remain Linked to Lower Risk for Real-World Adverse Outcomes
Magnitude of these associations decreases alongside increasing prescription rates
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants
AAP Offers Guidance for Genetic Evaluation of Neurodevelopmental Disorders
Three-tiered agnostic approach is proposed based on diagnostic yield and practical considerations
Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
High triglyceride-glucose index significantly associated with faster cognitive decline in the MCI-Alzheimer disease subgroup
Late-Life Mood Disorders May Indicate Predisposition to Dementia
Participants with LLMDs more likely to be tau PET- and amyloid β PET-positive compared with healthy controls
Nestle, Other Food Companies Vow to Ban Artificial Colors
Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine
Decrease seen in mean monthly headache days and reduction in Migraine Disability Assessment scores
